Global Biometric Head, Oncology
Sammi Tang is the Global Biometric Head of Oncology at Servier Pharmaceuticals and a leading expert of biostatistics and bioinformatics in the pharmaceutical industry.
Before joining Servier, Sammi was the Biostatistics Therapeutic Area Head of Oncology, Transplants and Prematurity Neonates at Shire Pharmaceuticals. Prior to that, she worked at Vertex Pharmaceuticals, where she led multiple oncology and hematology pipelines. Sammi also worked at Amgen, Mayo Clinical Biostatistics and Merck. Previously, she served as the biostatistics lead of Companion Diagnostics & Global Statistics Lead for multiple oncology clinical programs from early to late phases at Amgen. She is also an active member in American Statistics Association and International Chinese Statistics Association to serve the biostatistics and data science professional community.
Sammi has great experience in CDRH, CBER, CDER, health Canada, EMA and Asian regulatory agencies interactions. She has authored more than 35 articles in peer-reviewed scientific journals on methodology, study design, data analysis and reporting and is a co-inventor of several patents. Besides her daily work, Sammi actively promotes data science through volunteer activities. She is co-founder of a non-profit organization, DahShu, founded to promote research and education in data sciences with almost 5000 members internationally. She also leads teams in the Drug Information Association (DIA) design scientific working group of oncology drug development and small population working group for rare disease statistical methodology development.
Sammi graduated from the University of Michigan Technology University with a Doctor of Philosophy in statistics genetics.
To learn more about Sammi connect with her on LinkedIn.
More from Servier
Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.Learn More
Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.Learn More
Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history.Learn More